Literature DB >> 18955497

In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs.

Angela Cassese1, Iolanda Esposito, Francesca Fiory, Alessia P M Barbagallo, Flora Paturzo, Paola Mirra, Luca Ulianich, Ferdinando Giacco, Claudia Iadicicco, Angela Lombardi, Francesco Oriente, Emmanuel Van Obberghen, Francesco Beguinot, Pietro Formisano, Claudia Miele.   

Abstract

Chronic hyperglycemia promotes insulin resistance at least in part by increasing the formation of advanced glycation end products (AGEs). We have previously shown that in L6 myotubes human glycated albumin (HGA) induces insulin resistance by activating protein kinase Calpha (PKCalpha). Here we show that HGA-induced PKCalpha activation is mediated by Src. Coprecipitation experiments showed that Src interacts with both the receptor for AGE (RAGE) and PKCalpha in HGA-treated L6 cells. A direct interaction of PKCalpha with Src and insulin receptor substrate-1 (IRS-1) has also been detected. In addition, silencing of IRS-1 expression abolished HGA-induced RAGE-PKCalpha co-precipitation. AGEs were able to induce insulin resistance also in vivo, as insulin tolerance tests revealed a significant impairment of insulin sensitivity in C57/BL6 mice fed a high AGEs diet (HAD). In tibialis muscle of HAD-fed mice, insulin-induced glucose uptake and protein kinase B phosphorylation were reduced. This was paralleled by a 2.5-fold increase in PKCalpha activity. Similarly to in vitro observations, Src phosphorylation was increased in tibialis muscle of HAD-fed mice, and co-precipitation experiments showed that Src interacts with both RAGE and PKCalpha. These results indicate that AGEs impairment of insulin action in the muscle might be mediated by the formation of a multimolecular complex including RAGE/IRS-1/Src and PKCalpha.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18955497      PMCID: PMC2662288          DOI: 10.1074/jbc.M801698200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.

Authors:  T Nishikawa; D Edelstein; X L Du; S Yamagishi; T Matsumura; Y Kaneda; M A Yorek; D Beebe; P J Oates; H P Hammes; I Giardino; M Brownlee
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

Review 2.  Intervening in atherogenesis: lessons from diabetes.

Authors:  H Vlassara
Journal:  Hosp Pract (1995)       Date:  2000-11-15

Review 3.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 4.  Nutritional and toxicological aspects of the Maillard browning reaction in foods.

Authors:  J O'Brien; P A Morrissey
Journal:  Crit Rev Food Sci Nutr       Date:  1989       Impact factor: 11.176

Review 5.  The role of protein kinase C isoforms in insulin action.

Authors:  P Formisano; F Beguinot
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

6.  Regulation of vascular endothelial growth factor expression by advanced glycation end products.

Authors:  C Treins; S Giorgetti-Peraldi; J Murdaca; E Van Obberghen
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

Review 7.  Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease.

Authors:  A Flyvbjerg
Journal:  Diabetologia       Date:  2000-10       Impact factor: 10.122

8.  Selective attenuation of metabolic branch of insulin receptor down-signaling by high glucose in a hepatoma cell line, HepG2 cells.

Authors:  K Nakajima; K Yamauchi; S Shigematsu; S Ikeo; M Komatsu; T Aizawa; K Hashizume
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

9.  Insulin-activated protein kinase Cbeta bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells.

Authors:  P Formisano; F Oriente; F Fiory; M Caruso; C Miele; M A Maitan; F Andreozzi; G Vigliotta; G Condorelli; F Beguinot
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

10.  Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin.

Authors:  L V Ravichandran; D L Esposito; J Chen; M J Quon
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

View more
  48 in total

1.  Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes.

Authors:  Bryan C Bergman; David Howard; Irene E Schauer; David M Maahs; Janet K Snell-Bergeon; Robert H Eckel; Leigh Perreault; Marian Rewers
Journal:  J Clin Endocrinol Metab       Date:  2012-02-22       Impact factor: 5.958

Review 2.  Glycation and insulin resistance: novel mechanisms and unique targets?

Authors:  Fei Song; Ann Marie Schmidt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08       Impact factor: 8.311

3.  Diabetes and cancer: Looking at the multiligand/RAGE axis.

Authors:  Armando Rojas; Ileana González; Erik Morales; Ramón Pérez-Castro; Jacqueline Romero; Héctor Figueroa
Journal:  World J Diabetes       Date:  2011-07-15

4.  Advanced Glycation End Products: Building on the Concept of the "Common Soil" in Metabolic Disease.

Authors:  Henry H Ruiz; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Endocrinology       Date:  2020-01-01       Impact factor: 4.736

Review 5.  Insulin receptor signaling in normal and insulin-resistant states.

Authors:  Jérémie Boucher; André Kleinridders; C Ronald Kahn
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-01-01       Impact factor: 10.005

6.  Circulating soluble RAGE isoforms are attenuated in obese, impaired-glucose-tolerant individuals and are associated with the development of type 2 diabetes.

Authors:  Edwin R Miranda; Vikram S Somal; Jacob T Mey; Brian K Blackburn; Edward Wang; Sarah Farabi; Kristian Karstoft; Ciaran E Fealy; Sangeeta Kashyap; John P Kirwan; Laurie Quinn; Thomas P J Solomon; Jacob M Haus
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-08-15       Impact factor: 4.310

7.  Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia.

Authors:  Massimo Torreggiani; Huixian Liu; Jin Wu; Feng Zheng; Weijing Cai; Gary Striker; Helen Vlassara
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

8.  AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease.

Authors:  Weijing Cai; Massimo Torreggiani; Li Zhu; Xue Chen; John Cijiang He; Gary E Striker; Helen Vlassara
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-02       Impact factor: 4.249

Review 9.  Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine.

Authors:  Jean Robert Rapin; Nicolas Wiernsperger
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

10.  Semiquantitative analysis of apolipoprotein A-I modified by advanced glycation end products in diabetes mellitus.

Authors:  Yoshifumi Kurosaki; Tomoaki Tsukushi; Shinichi Munekata; Tohru Akahoshi; Tatsumi Moriya; Zensuke Ogawa
Journal:  J Clin Lab Anal       Date:  2013-02-25       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.